The advance of Russian troops towards Kramatorsk is blocked by the Kazennaya Torets river, and Russian forces have resorted to improvised solutions, such as an armored vehicle adapted with a metal bridge. This "turtle tank" is intended to allow for the rapid crossing of other armored vehicles and infantry. Although the device is rudimentary and has already been abandoned in confrontations, it signals a tactical shift, with Russia reorienting from urban fighting to open terrain.
The river represents a major obstacle, with Russian troops having difficulties in supplying their bases on the opposite bank. Infantry-based tactics are less effective in open fields, exposing Russian troops to Ukrainian drones. Although Russia has attempted direct crossings, many of these have failed, and the improvised vehicles could provide a temporary solution. Analysts warn that if these vehicles become more common, the Kazennaya Torets river could become a less significant barrier for the Russian advance.
The river represents a major obstacle, with Russian troops having difficulties in supplying their bases on the opposite bank. Infantry-based tactics are less effective in open fields, exposing Russian troops to Ukrainian drones. Although Russia has attempted direct crossings, many of these have failed, and the improvised vehicles could provide a temporary solution. Analysts warn that if these vehicles become more common, the Kazennaya Torets river could become a less significant barrier for the Russian advance.
Sources
Latest News
19:05
ANPC warns about the phenomenon of "shrinkflation" / Consumers are urged to check the net quantity and the price per kilogram or liter
18:48
Man died after drowning in the sea, at Eforie Nord. He ignored the red flag and was rescued from the water by lifeguards three times.
18:30
Nicușor Dan and Maia Sandu discussed in Chișinău about European integration and energy security
18:18
Ilie Bolojan: Over 2,000 PNRR projects received in August / Unfinished works will be paid for by local authorities
18:08
The pharmaceutical group Minapharm will develop a candidate vaccine against the Bundibugyo Ebola strain, with funding of 16.5 million dollars.
See more news